Roberta Firnhaber White

Roberta Firnhaber White

Auto-generated profile, based on publicly available information

Roberta Firnhaber White

Department of Environmental Health, Boston University School of Public Health, Boston, USA

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1997 in Neurotoxicology and Teratology
Verified
Journal Article
Open access
PGPhilippe Grandjean
Philippe Grandjean
PWPal Weihe
Pal Weihe
RWRoberta F White
Roberta F White
FDFrodi Debes
Frodi Debes
SAShunichi Araki
Shunichi Araki
PJPoul J Jørgensen
Poul J Jørgensen
A cohort of 1022 consecutive singleton births was generated during 1986-1987 in the Faroe Islands. Increased methylmercury exposure from maternal consumption of pilot whale meat was indicated by mercury concentrations in cord blood and maternal hair. At approximately 7 years of age, 917 of the children underwent detailed neurobehavioral examination. Neuropsychological tests included Finger Tapping; Hand-Eye Coordination; reaction time on a Continuous Performance Test; Wechsler Intelligence Scale for Children-Revised Digit Spans, Similarities, and Block Designs; Bender Visual Motor Gestalt Test; Boston Naming Test; and California Verbal Learning Test (Children). Clinical examination and neurophysiological testing did not reveal any clear-cut mercury-related abnormalities. However, mercury-related neuropsychological dysfunctions were most pronounced in the domains of language, attention, and memory, and to a lesser extent in visuospatial and motor functions. These associations remained after adjustment for covariates and after exclusion of children with maternal hair mercury concentrations above 10 microgram(s) (50 nmol/g). The effects on brain function associated with prenatal methylmercury exposure therefore appear widespread, and early dysfunction is detectable at exposure levels currently considered safe.

1 May 1998 in Environmental Research
Verified
Journal Article
Open access
PGPhilippe Grandjean
Philippe Grandjean
PWPal Weihe
Pal Weihe
RWRoberta F. White
Roberta F. White
FDFrodi Debes
Frodi Debes
Within a cohort of 1022 consecutive singleton births in the Faroe Islands, we assessed prenatal methylmercury exposure from the maternal hair mercury concentration. At approximately 7 years of age, 917 of the children underwent detailed neurobehavioral examination. Little risk is thought to occur as long as the hair mercury concentration in pregnant women is kept below 10-20 microg/g (50-100 nmol/l). A case group of 112 children whose mothers had a hair mercury concentration of 10-20 microg/g was therefore matched to children with exposure below 3 microg/g, using age, sex, time of examination, and the mother's score on Raven's Progressive Matrices as matching criteria. The two groups were almost identical with regard to other factors that might affect neurobehavioral performance in this community. On six neuropsychological test measures, the case group showed mild decrements, relative to controls, especially in the domains of motor function, language, and memory. Subtle effects on brain function therefore seem to be detectable at prenatal methylmercury exposure levels currently considered to be safe.

1 June 2000 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
MEMerrill F. Elias
Merrill F. Elias
ABAlexa Beiser
Alexa Beiser
PWPhilip A. Wolf
Philip A. Wolf
RARhoda Au
Rhoda Au
RWRoberta F. White
Roberta F. White
RDRalph B. D'Agostino
Ralph B. D'Agostino
THE "PRECLINICAL phase" of dementia refers to a period of cognitive decline that precedes the onset of Alzheimer disease (AD).1 Early detection of AD will be increasingly important as research advances with respect to prognostic methods and therapeutic interventions.2,3 Therefore, it is important to determine the time line and the earliest evidence of cognitive decline signaling the preclinical phase of AD and to identify specific neuropsychological tests that have clinical utility in the prediction of this disorder.

1 December 1997 in Neurology
Verified
Journal Article
Closed access
PDF file
SSS. Seshadri
S. Seshadri
PWP. A. Wolf
P. A. Wolf
ABA. Beiser
A. Beiser
RAR. Au
R. Au
Kimberly SullivanKimberly Sullivan
Kimberly Sullivan
RDR. B. D'AGostino
R. B. D'AGostino
We estimated the remaining lifetime risks of developing Alzheimer9s disease (AD) and dementia from all causes, based on data from longitudinal population studies. The risk of developing AD during one9s lifetime depends on both disease incidence and life expectancy. Conventional estimates of cumulative incidence overestimate the risk when there is a substantial probability of mortality due to competing causes. A total of 2,611 cognitively intact subjects (1,061 men, 1,550 women; mean age, 66± 7 years) were prospectively evaluated for the development of AD or other dementia. A modified survival analysis was used to estimate both cumulative incidence and the sex-specific remaining lifetime risk estimates for quinquennial age groups above age 65 years. Over a 20-year follow-up period, 198 subjects developed dementia (120 with AD). The remaining lifetime risk of AD or other dementia depended on sex, being higher in women, but varied little with age between 65 and 80 years. In a 65-year-old man, the remaining lifetime risk of AD was 6.3% (95% CI, 3.9 to 8.7) and the remaining lifetime risk of developing any dementing illness was 10.9% (95% CI, 8.0 to 13.8); corresponding risks for a 65-year-old woman were 12% (95% CI, 9.2 to 14.8) and 19% (95% CI, 17.2 to 22.5). The cumulative incidence between age 65 and 100 years was much higher: for AD, 25.5% in men and 28.1% in women; for dementia, 32.8% in men and 45% in women. The actual remaining lifetime risk of AD or dementia varies with age, sex, and life expectancy and is lower than the hypothetical risk estimated by a cumulative incidence in the same population.

1 January 2016 in Cortex
Verified
Journal Article
Open access
RWRoberta F. White
Roberta F. White
LSLea Steele
Lea Steele
JOJames O'Callaghan
James O'Callaghan
Kimberly SullivanKimberly Sullivan
Kimberly Sullivan
JBJames H. Binns
James H. Binns
RGRachel Grashow
Rachel Grashow
Veterans of Operation Desert Storm/Desert Shield - the 1991 Gulf War (GW) - are a unique population who returned from theater with multiple health complaints and disorders. Studies in the U.S. and elsewhere have consistently concluded that approximately 25-32% of this population suffers from a disorder characterized by symptoms that vary somewhat among individuals and include fatigue, headaches, cognitive dysfunction, musculoskeletal pain, and respiratory, gastrointestinal and dermatologic complaints. Gulf War illness (GWI) is the term used to describe this disorder. In addition, brain cancer occurs at increased rates in subgroups of GW veterans, as do neuropsychological and brain imaging abnormalities. Chemical exposures have become the focus of etiologic GWI research because nervous system symptoms are prominent and many neurotoxicants were present in theater, including organophosphates (OPs), carbamates, and other pesticides; sarin/cyclosarin nerve agents, and pyridostigmine bromide (PB) medications used as prophylaxis against chemical warfare attacks. Psychiatric etiologies have been ruled out. This paper reviews the recent literature on the health of 1991 GW veterans, focusing particularly on the central nervous system and on effects of toxicant exposures. In addition, it emphasizes research published since 2008, following on an exhaustive review that was published in that year that summarizes the prior literature (RACGWI, 2008). We conclude that exposure to pesticides and/or to PB are causally associated with GWI and the neurological dysfunction in GW veterans. Exposure to sarin and cyclosarin and to oil well fire emissions are also associated with neurologically based health effects, though their contribution to development of the disorder known as GWI is less clear. Gene-environment interactions are likely to have contributed to development of GWI in deployed veterans. The health consequences of chemical exposures in the GW and other conflicts have been called "toxic wounds" by veterans. This type of injury requires further study and concentrated treatment research efforts that may also benefit other occupational groups with similar exposure-related illnesses.

1 July 2001 in Neurotoxicology and Teratology
Verified
Journal Article
Closed access
PGPhilippe Grandjean
Philippe Grandjean
PWPal Weihe
Pal Weihe
VBVirlyn W. Burse
Virlyn W. Burse
LNLarry L. Needham
Larry L. Needham
ESEva Storr-Hansen
Eva Storr-Hansen
RWRoberta F. White
Roberta F. White